FIELD: pharmaceutics.
SUBSTANCE: invention relates to a compound of formula A-B-C (I), where A is 
; B is -(C2-C6)-alkylene-C(O)N(R)-; C is 
; R is H; R1 is independently H, (C1-C6)alkyl or CF3; R2 is H, (C1-C6)alkyl, substituted or unsubstituted (C6)aryl, (C3-C6)cycloalkyl, -(C2-C6)alkylene-(C1-C6)alkoxy, (C1-C6)alkylene-(C6)aryl, substituted or unsubstituted pyridinyl, indolyl or 2,3-dihydrobenzofuranyl; R3 is H or a halide; R6 and R7 independently represent H or a halide; and n' is independently 0, 1 or 2; or a pharmaceutically acceptable salt thereof. Also disclosed is a pharmaceutical composition.
EFFECT: disclosed compounds are low-molecular integrin inhibitors αvβ6 and can be used to treat a number of diseases and pathological conditions.
31 cl, 1 dwg, 34 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF AKT ACTIVITY | 2010 |
|
RU2579513C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS | 2011 |
|
RU2652638C2 |
| INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
| COMPOUNDS | 2016 |
|
RU2725616C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| 1,5-NAPHTHRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THEM | 2012 |
|
RU2645339C1 |
| FLUORINE-CONTAINING INTEGRIN ANTAGONISTS | 2014 |
|
RU2698195C2 |
| ANTAGONISTS OF SOMATOSTATIN RECEPTOR SUBTYPE 5 (SSTR5) | 2014 |
|
RU2671958C2 |
| IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
